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Abstract. Metal containing polymers have expanded the property 
of polymers by involving covalently associated metal complexes. 
DNA is a special block copolymer. While metal ions are known 
to influence DNA, little is explored on its polymer property when 
strong metal complexes are associated. In this work, we study 10 
cisplatin modified DNA as a new polymer and probe. Out of the 
complexes formed between cisplatin/A15, HAuCl4/A15, Hg2+/T15 
and Ag+/C15, only the cisplatin adduct is stable under the 
denaturing gel electrophoresis condition. Each Pt-nucleobase 
bond gives a positive charge and thus makes DNA a zwitterionic 15 
polymer. This allows ultrafast adsorption of DNA by graphene 
oxide (GO) and the adsorbed complex is highly stable. Non-
specific DNA, protein, surfactants and thiolated compounds 
cannot displace platinated DNA, while non-modified DNA is 
easily displaced in most cases. The stable GO/DNA conjugate is 20 
further tested for surface hybridization. This is the first 
demonstration of using metallated DNA as a polymeric material 
for interfacing with nanoscale materials. 
1. Introduction 
DNA is a polymer composed of phosphate, pentose and four 25 
types of nucleobases. These simple building blocks have 
already enabled complex biological and chemical functions 
including storage of genetic information, molecular 
recognition and catalysis.1 The function of DNA can be 
further expanded by introducing covalent modifications such 30 
as optical and electrochemical labels, modified backbone or 
bases.2 
 In addition, the property of a DNA is also influenced by 
metal ions. Since DNA is a polyanion, metal ions bind to its 
backbone phosphate via electrostatic attraction, although the 35 
affinity is often weak and the association is transient. DNA 
bases are good ligands for transition metals.3 Well known 
examples include the binding of Hg2+ by thymine,4 Ag+ by 
cytosine,5 and Au3+ by adenine and cytosine (see Figure 1A).6 
In more complex systems, a few DNA bases may form 3D 40 
binding pockets to interact with metal ions. The best examples 
are metal-specific aptamers and DNAzymes, where Pb2+,7 
Zn2+,8-10 Hg2+,4,11 UO22+,12 and lanthanides13,14 are selectively 
associated. Given these developments, most metal ions bind 
reversibly to DNA with fast exchange rates, thus disqualifying 45 
them as modified DNA. 
 Stable metal-DNA complexes are formed in a few cases, 
where they often involve Group 8B metals. For example, Ru2+ 
and Os2+ complexes form adducts with DNA, which are stable 
in electrospray ionization (ESI) mass spectrometry conditions. 50 
Their coordination and binding energy to DNA bases have 
been predicted by DFT calcutions.15 Dirhodium complexes 
coordinate with the N7 and O6 positions on guanine.16 
Osmium tetraoxide reacts with both the ribose and thymine 
bases.17 The best known example is the adduct formed 55 
between cisplatin and guanine or adenine (Figure 1A). 
Cisplatin is the most successful and important anti-cancer 
drug.18-21 Its interaction with DNA has been extensively 
studied.22 Cisplatin favorably reacts with the N7 position of 
adenine and guanine to form stable adducts. 60 
 DNA-metal adducts are called metallated DNA, where a 
metal center directly forms a strong covalent bond with DNA. 
Metallated DNA is different from metallized DNA. In a 
metallized DNA, metal nanoparticles are formed around a 
DNA template,23,24 and DNA plays only a sacrificial structural 65 
role.25 While metallated DNA is an important topic in 
medicine and have been proposed for microscopy-based DNA 
sequencing,26 they have not been studied as a new polymer or 
an analytical probe, and its interaction with nanomaterials has 
not been explored. Many synthetic metal containing polymers 70 
have been grafted onto DNA,27 and many metal containing 
polymers have been prepared,28 but direct metal/DNA 
bonding is rare in this context. We are interested in metallated 
DNA since they may achieve new properties that cannot be 
easily realized by traditional organic modifications. Herein, 75 
we explore the reaction between cisplatin and DNA and 
compare it with other metal ions. As an example of 
application, the cisplatin-DNA adduct is highly stably 
adsorbed by graphene oxide (GO). 
 80 
2. Results and Discussion.  
Metal affinity comparison. To qualify for metallated DNA, 
metal binding has to be strong enough and stable. For 
example, when free metal ions are removed, the associated 
metal should still bind the DNA. Usually, transition metal 85 
ions bind to DNA more strongly than alkaline earth metals do. 
The binding strength with DNA follows the order of 
Mg2+<Co2+<Ni2+<Mn2+<Zn2+<Cd2+<Cu2+<Ag+<Hg2+.29 The 
affinity for Au3+ and Pt2+ should be even higher. For example, 
the bond energy is calculated to be 94.1 and 117.9 kJ/mol for 90 
Pt2+ binding to adenine and guanine binding respectively.30  
  
 
Figure 1. (A) Coordination of metal ions by various DNA 
bases. Denaturing gel images of AF-A15 reacting with various 5 
concentrations of cisplatin (B), or with HAuCl4 (C); FAM-C15 
with Ag+ (D) and AF-T15 with Hg2+ (E). The DNA 
concentration was fixed at 0.5 M. (F) Reaction scheme 
between cisplatin and adenine, producing a positive charge on 
the adduct. 10 
 
 To systematically compare the stability of the complexes 
formed between DNA and metal ions, we chose four high 
affinity systems. In the first two cases, an A15 DNA (e.g. a 15-
mer DNA with all adenine bases) is respectively reacted with 15 
cisplatin and HAuCl4. Pt2+ and Au3+ have the same electronic 
structure and are right next to each other the periodic table, 
forming a good pair for comparison. In addition, we also 
studied T15 reacting with Hg2+ and C15 with Ag+. All the DNA 
samples contain a fluorophore label on the 5-end and the 20 
products were analyzed by denaturing gel electrophoresis. For 
the cisplatin/AF-A15 mixture (AF = Alexa Fluor 647), the free 
DNA has the highest mobility (first lane, Figure 1B). The Pt-
DNA adducts migrate more slowly in the presence of higher 
concentration of cisplatin, suggesting more cisplatin 25 
molecules are associated with the DNA.31 We emphasize that 
the cisplatin adduct is stable enough to survive the denaturing 
gel conditions (e.g. 8 M urea and strong electric field). The 
decreased DNA mobility suggests that the DNA carries fewer 
negative charges after reacting with cisplatin. This is 30 
reasonable since replacing the chloride ligand with a charge 
neutral adenine gives rise to a positive charge (Figure 1E). 
Mixing HAuCl4 with DNA, on the other hand, did not result 
in a change in the gel mobility; only quenched fluorescence 
was observed at high gold concentrations (Figure 1C). The 35 
lack of mobility change is likely due to instability of the Au-
DNA adduct in the gel. To understand fluorescence 
quenching, we mixed FAM-A15 with HAuCl4 in solution 
(Figure S1), where fluorescence quenching was also observed. 
The quenched fluorescence was recovered by adding KCN, 40 
which is a strong ligand for gold. On the other hand, adding 
HAuCl4 to the free fluorescein fluorophore (no DNA) did not 
produce much fluorescence quenching. Therefore, HAuCl4 
does not bind to the fluorophore itself but forms adducts with 
the poly-A DNA to quench fluorescence. FAM-C15 was also 45 
tested with HAuCl4 and little shift in gel was also observed 
either (Figure S2). The Ag+/FAM-C15 and Hg2+/AF-T15 
mixtures migrated at the same speed as the metal free samples 
too, and only Hg2+ resulted in moderate quenching at high 
concentration (Figure 1D, E). This study indicates that out of 50 
the four tested combinations, only the cisplatin adduct is 
stable enough to be qualified as metallated DNA. It is known 
that cisplatin binds to guanine even more strongly. We chose 
to study poly-A DNA since it does not suffer from artifacts 
that may arise from guanine quadruplex structures. 55 
  
 
 
Figure 2. Mass spectrum of A15 (20 M) + cisplatin (100 M) 
incubated for 6 h (A) and 50 h (B). The region of species in 60 
mass spectrometer with 5 negative charges is shown. 
 
 To quantify the number of Pt associated with each DNA, 
we performed mass spectrometry experiments, in which 20 
M A15 DNA was incubated with 100 M cisplatin. After 6 h 65 
reaction (Figure 2A), a strong peak of free DNA can still be 
observed; mono and dual platinated DNAs are the main 
species. After 50 h incubation (Figure 2B), the free DNA peak 
disappeared and 2 or 3 Pt adducts are the main species. We 
used a ratio of cisplatin:DNA=5:1, and the highest platinated 70 
DNA contains just 4 Pt. The mass spectra of the free DNA 
and the isotope effects are shown in Figure S3 and S4. The 
mass spectrometry results indicate that the reaction between 
DNA and cisplatin is quite slow. 
Fast adsorption by GO. Our above experiments indicate that 
the Pt-DNA adduct is stable and might be used as a new 5 
polymer for further studies. Previous work showed that the 
melting temperature (Tm) of a DNA duplex is decreased by a 
cisplatin adduct in most buffer condition.32 However, with 
very low salt concentration (e.g. <1 mM NaCl), the cisplatin 
adduct can slightly increase the Tm as well.33 Cisplatin also 10 
bends duplex DNA by bridging two adjacent guanines.34 Most 
of the previous works involved double-stranded DNA. In this 
work, we study the property of ss-DNA. Since platinated 
DNA bases carry a positive charge (Figure 1F), it might be 
useful for enhancing the interaction between DNA and 15 
negatively charge materials. In this study, we used graphene 
oxide (GO) for proof-of-concept. 
 Graphene is a newly discovered nanomaterial with many 
interesting properties. To disperse in water, GO with carboxyl 
and hydroxyl groups is often used. GO effectively adsorbs 20 
single-stranded DNA and acts as a fluorescence quencher at 
the same time, and fluorescently labeled probe DNA has been 
used as a sensor for DNA detection.35-39 In the presence of 
cDNA, the probe is desorbed from the GO surface to enhance 
fluorescence signal. For this application, the probe DNA 25 
needs to be adsorbed strongly enough to give a stable 
background signal but weakly enough to be quickly desorbed 
by the cDNA. For other applications, it might be desirable to 
have more stable adsorption (e.g. irreversible). Although 
covalent linkage can be achieved by forming amide bonds 30 
using amino modified DNA, most DNA can only be attached 
to the edge of GO, where carboxyl groups are located.40,41 In 
addition, it is difficult to wash away non-covalently linked 
DNA.42 If a strong and stable physisorption can be achieved, 
many more applications can be enabled. We aim to test 35 
whether platinated DNA can be used for this purpose and 
DNA adsorption was first studied as schematically shown in 
Figure 3A. 
 To enhance electrostatic interaction, the DNA adsorption 
experiment was first carried out in the absence of salt (i.e. low 40 
ionic strength). To achieve platination, AF-A15 was incubated 
with cisplatin for various amount of time. A longer incubation 
corresponds to more cisplatin attached, as indicated by our gel 
and mass spectrometry studies. The fluorescence of these 
samples was monitored for 5 min before GO was added 45 
(Figure 3B). Without cisplatin treatment, the DNA was not 
adsorbed by GO since no fluorescence quenching was 
observed (blue line). This is because both DNA and GO are 
negatively charged and they strongly repel each other in the 
low salt buffer. After longer incubation with cisplatin, we 50 
observed progressively faster DNA adsorption. With 4 h 
incubation, fluorescence went to the background level in ~10 
min after mixing with GO, suggesting complete adsorption. 
As a control experiment, AF-T15 was treated with cisplatin the 
same way and then mixed with GO. The fluorescence did not 55 
change much even after incubating with cisplatin for 4 h 
(Figure 2C). This is consistent with the low affinity between 
thymine and cisplatin. Therefore, cisplatin has to covalently 
bind to DNA to be effective; it cannot act as a salt for non-
specific charge screening. This also confirms that Pt addition 60 
has reduced the number of negative charges on DNA, 
facilitating its interaction with GO. 
 
 
Figure 3. (A) A scheme of fluorescently labeled DNA and 65 
platinated DNA adsorption by GO in low salt buffer. 
Adsorption results in fluorescence quenching. Kinetics of 
cisplatin treated AF-A15 (B) and AF-T15 (C) adsorption by 
GO. (D) Adsorption of AF-A15 after HAuCl4 treatment in low 
salt buffer or non-treated DNA in high salt buffer. 70 
 
 Adding a positive charge to DNA bases can also be realized 
by lowering pH to protonate adenine (pKa =3.5) and cytosine 
(pKa = 4.2). This method was used for assisting DNA 
adsorption to gold,43,44 silver,45 and GO previously.46 Even 75 
though DNA is still overall negatively charged, the cationic 
bases can significantly change the interaction kinetics and 
stability of DNA with surfaces. In the case of platinated DNA, 
the fast DNA adsorption reaction was achieved at neutral pH. 
As a control experiment, the same reaction was performed 80 
with HAuCl4 treated AF-A15. With 10 M HAuCl4 (Au:AF-
A15 = 5:1), the fluorescence was quenched by 80% (Figure 
3D, red curve), suggesting the association of Au to the DNA. 
However, addition of GO at 5 min did not induce much 
further quenching, indicating the lack of DNA adsorption. 85 
Further increase of gold concentration resulted in complete 
fluorescence quenching (green curve), disallowing us to study 
its adsorption by GO. It might be that AuCl4- originally carries 
a negative charge and binding to DNA makes it charge neutral 
and it does not assist DNA adsorption. It needs to be noted 90 
that achieving DNA adsorption by GO is not a difficult task. 
For example, by using a high ionic strength buffer (black 
curve, Figure 3D), fast DNA adsorption was observed in the 
absence of gold or platinum. We did most of the adsorption 
experiments in the absence of salt to highlight the electrostatic 95 
effect of platination.  
    
Highly stable conjugates. The above experiments have 
established the kinetic advantage of using Pt-DNA to attach to 
GO under low salt conditions. For many applications, it is 100 
more important to have a stable DNA/GO conjugate.42,47,48 
Next, we compared adsorption affinity between unmodified 
and cisplatin treated AF-A15. To facilitate adsorption of 
unmodified DNA, a buffer with high salt concentration was 
used. Then both systems were treated with molecules that 
might compete with the adsorbed DNA in a real sample 5 
matrix. The scheme of the displacement reaction is shown in 
Figure 4A, where displaced DNA produces fluorescence 
signal. After adding non-labeled A15 DNA, significant 
fluorescence enhancement was observed for the unmodified 
DNA/GO complex but the cisplatin treated DNA remained 10 
stably adsorbed (Figure 4B). Similar observations were made 
with bovine serum albumin (BSA, Figure 4C) and with a 
surfactant (Triton X-100, Figure 4D). When a thiol containing 
peptide, GSH, was added, no DNA displacement was 
observed for either sample (Figure 4E). We used GSH since it 15 
might bind to platinum and thus weaken the DNA adsorption 
affinity. This set of experiments established the 
thermodynamic stability of the platinated DNA/GO 
interaction.  
 Of note, although cisplatin might directly react with 20 
carboxyl groups (such as those on GO), this is unlikely to 
happen in our system. We first reacted cisplatin with DNA, 
and the Pt center was coordinated by strong ammonia and 
adenine. Therefore, weaker carboxyl ligands are unlikely to 
displace these stronger ones. We attribute the stable 25 
adsorption of cisplatin treated DNA to charge interaction 
instead of using Pt as a covalent bridge to link DNA and GO. 
For practical application, the affinity is strong enough to 
survive harsh conditions that might be encountered in 
challenging applications. 30 
 
 
Figure 4. (A) Schematics showing adsorbed DNA can be 
easily displaced, resulting in fluorescence enhancement, while 
platinated DNA is stably adsorbed. Kinetics of DNA 35 
displacement by adding A15 (B), BSA (C), Triton X-100 (D) 
and GSH (E). Increased fluorescence is due to displacement of 
adsorbed DNA probes. 
 
DNA Hybridization on GO. This highly efficient and stable 40 
adsorption of Pt-DNA by GO might lead to useful 
applications. In addition to making biosensors, DNA/GO 
complexes have also been used for assembling nanomaterials. 
In this case, a high affinity between DNA and GO is needed. 
Since the binding affinity of poly-A DNA to GO is higher 45 
than that for poly-T DNA, a poly-A block was used to anchor 
on GO.49 Despite such applications, as we shown here, it is 
still possible to displace adsorbed DNA by various types of 
competing molecules, producing background signal. These 
problems might be alleviated by using platinated DNA. To 50 
test the function of adsorbed platinated DNA, we designed a 
sequence of A15T30. Since cisplatin selectively reacts with the 
adenine base, this platinated di-block DNA should stably 
anchor on the GO surface using the poly-A block, and the 
poly-T part is still available for hybridization (Figure 5A). 55 
Indeed, as shown in Figure 5B, the Pt-DNA/GO conjugate 
effectively hybridized with FAM-A30, since the sample was 
highly fluorescent under microscope. For comparison, the 
same DNA without cisplatin treatment or the FAM-A30 alone 
did not produce noticeable fluorescence. A transmission 60 
micrograph of the GO sheets is shown in Figure S5. Note we 
used a low salt buffer for the DNA adsorption step; the lack of 
fluorescence is mainly attributed to the failure of 
immobilizing non-platinated A15T30 DNA. When the 
adsorption step was carried out in a high salt buffer (Figure 65 
5C), the fluorescence signal was still much stronger with the 
cisplatin treated DNA, suggesting a much higher DNA density 
on the GO surface. This experiment indicates that Pt-DNA can 
form a stable conjugate with GO and the remaining DNA 
fragment is still functional as a normal DNA probe for 70 
hybridization. 
   
 
 
Figure 5. Schematics of reacting a Pt-DNA with GO and its 75 
further hybridization with FAM-labeled DNA to make the GO 
surface fluorescent. Fluorescence micrographs when DNA 
adsorption on GO was at low salt concentration (B) and at 
high salt buffer (C). Scale bars = 1 mm.  
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3. Conclusions. 
In summary, we compared the stability of complexes formed 
between DNA and a few transition metals and metal 
complexes. Among these, the adduct formed between cisplatin 
and DNA has the highest stability and can be used as a new 
metal containing polymer. This adduct shows fast adsorption 5 
by GO and forms a very stable adsorption complex. This is 
attributed to the positive charges brought by bonding the Pt 
center to the DNA bases. This system allows a much higher 
DNA density on the GO surface, while still retaining the 
hybridization property of DNA probes. This work suggests 10 
that metallated DNA is a new type of metal containing 
polymer with useful properties for analytical and biomedical 
applications. 
 
MATERIALS AND METHODS 15 
Chemicals. All the DNA samples were purchased from 
Integrated DNA Technologies Inc. (IDT, Coralville, IA). The 
non-labeled and FAM-labeled DNAs were purified by 
standard desalting. The AF-labeled DNAs were purified by 
HPLC. GO was purchased from ACS Material, LLC 20 
(Medford, MA). Chloroauric acid trihydrate was purchased 
from Fisher Scientific. Cis-diammineplatinum(II) dichloride 
(cisplatin), mercury(II) perchlorate, silver nitrate, Triton X-
100, glutathione (GSH) and bovine serum albumin (BSA) 
were from Sigma-Aldrich. Tetramethylethylenediamine 25 
(TEMED), urea, ammonium persulfate (APS) and 
acrylamide/bis-acrylamide (29:1) solution 40% (w/v) were 
obtained from Bio Basic Inc (Markham, ON, Canada). Sodium 
citrate and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) were purchased from Mandel Scientific Inc 30 
(Guelph, ON, Canada). Milli-Q water was used to prepare all 
the buffers and solutions. 
DNA adsorption kinetics. To measure the adsorption kinetics 
of AF-A15/cisplatin adduct by GO, the adduct was first 
prepared by mixing AF-A15 (2 μM) and cisplatin (1 mM) for 35 
different incubation time (0, 0.5, 1, 2, 4 h). Then 2 μL of the 
mixtures were respectively added to 98 μL HEPES (10 mM, 
pH 7.6) and the samples were monitored for 5 min using a 
SpectraMax M3 microplate reader by exciting at 640 nm 
(emission at 668 nm). Then 2 μL nano-GO (500 μg mL-1) was 40 
added to the mixtures and the samples were monitored for 
another 40 min. AF-T15/cisplatin was also prepared for 
comparison. To adsorb AF-A15 in high salt buffer, 2 μL AF-
A15 (2 μM) was added to 98 μL HEPES (10 mM, pH 7.6) with 
100 mM NaCl and 2 mM MgCl2. The samples were monitored 45 
for 5 min and then 2 μL nano-GO (500 μg mL-1) was added. 
The method for preparing nano-GO was described 
previously.{Wang, 2013 #11202} 
DNA desorption kinetics. To understand desorption, AF-A15 
(2 μM) was mixed with cisplatin (1 mM) for 16 h. Then, 10 50 
μL of the AF-A15/cisplatin mixture was added to 90 μL 
HEPES (10 mM) for 5 min and 2 μL nano-GO (500 μg mL-1) 
was added. After 60 min, the buffer was adjusted to contain a 
final of 100 mM NaCl and 2 mM MgCl2. To test the 
displacement,  5 μL A15 (100 mM), BSA (100 mg mL-1), GSH 55 
(200 mM) or Triton X-100 (1%) were respectively added and 
the samples were monitored for another 60 min. As a control 
group, the desorption kinetics of AF-A15 with nano-GO were 
also investigated under the same condition. To test whether 
AF-A15/Au can be adsorbed by nano-GO, AF-A15/Au was 60 
prepared by mixing AF-A15 (2 μM) with HAuCl4 (10 or 20 
μM) for 1 h. Other procedures were the same as for the 
cisplatin samples. 
DNA hybridization on GO. For the data shown in Figure 5B 
(low salt adsorption), 5 μL of 100 μM A15T30 was mixed with 65 
100 μL of 1 mM cisplatin in Milli-Q water for 16 h at room 
temperature. Then 10 μL GO (500 μg mL-1) was added to this 
solution and incubated for another hour. After centrifugation 
at 15,000 rpm for 10 min and washed by HEPES (10 mM, pH 
7.6) twice, the Pt-DNA/GO complex was re-suspended in 100 70 
μL high salt buffer A (100 mM HEPES, 300 mM NaCl, 4 mM 
MgCl2). 5 μL FAM-A30 (10 μM) was then added to the sample 
and incubated for 1 h. After that, the mixture was centrifuged 
at 15,000 rpm for 10 min and washed by buffer A twice. The 
sample was prepared by pipetting a drop of the aqueous 75 
solution onto the coverslip and visualized under an inverted 
epi-fluorescence microscope (Eclipse Ti-S, Nikon) with a 
CCD camera (Qimaging Retiga 2000R Fast 1394). For 
comparison, 10 μL GO (500 μg mL-1) was directly added to 
either 100 μL 5 μM A15T30 dissolved in water or just Milli-Q 80 
water. For data in Figure 5C (high salt adsorption), 5 μL of 
100 μM A15T30 was mixed with 100 μL of 1 mM cisplatin in 
Milli-Q water for 16 h at room temperature. Then 10 μL GO 
(500 μg mL-1) was added to this solution and high salt 
solution was obtained by adding salt to a solution with high 85 
salt (100 mM HEPES, 300 mM NaCl, 4 mM MgCl2). The 
mixture was incubated for 1 h. As comparison, 10 μL GO 
(500 μg mL-1) was added to 100 μL 5 μM A15T30 dissolved in 
buffer A and incubated for another hour. Other procedures 
were the same as for the low salt adsorption. 90 
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